1. Home
  2. RNLX

RNLX

Renalytix plc

Logo Renalytix plc

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 10:31am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Founded: 2018 Country:
United States
United States
Employees: N/A City: LONDON
Market Cap: 59.2M IPO Year: 2020
Target Price: $5.00 AVG Volume (30 days): 1.9M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.90 EPS Growth: N/A
52 Week Low/High: $0.24 - $4.04 Next Earning Date: 06-07-2024
Revenue: $2,410,000 Revenue Growth: -36.65%
Revenue Growth (this year): 48.4% Revenue Growth (next year): 104.00%

Share on Social Networks: